US Stock MarketDetailed Quotes
ENTBF ENTHEON BIOMEDICAL CORP
- 0.119920
- +0.043020+55.94%
15min DelayClose Apr 15 16:00 ET
708.60KMarket Cap-3331P/E (TTM)
0.119920High0.079000Low2.43KVolume0.079000Open0.076900Pre Close274.21Turnover0.04%Turnover RatioLossP/E (Static)5.91MShares0.29000052wk High3.07P/B708.60KFloat Cap0.04300052wk Low--Dividend TTM5.91MShs Float5.714700Historical High--Div YieldTTM53.21%Amplitude0.040000Historical Low0.113000Avg Price1Lot Size
About ENTHEON BIOMEDICAL CORP Company
Entheon Biomedical Corp. is a biotechnology company, which engages in developing and commercializing dimethyltryptamine based psychedelic therapeutic products. Its therapies aim to treat addiction and substance use disorders. The company was founded on April 6, 2010 and is headquartered in Vancouver, Canada.
Company Profile
SymbolENTBF
Company NameENTHEON BIOMEDICAL CORP
Founded2010
MarketPink Market
Securities TypeOrdinary Shares
Fiscal Year Ends11-30
Address999 West Broadway,Suite 720
CityVancouver
ProvinceBritish Columbia
CountryCanada
Zip CodeV5Z 1K5
Phone1-604-562-3932
Company Executives
- Name
- Position
- Salary
- Timothy Ko
- Director
- --
- Christopher Gondi
- Director
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg